• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Fitbit and Quest Diagnostics Launches Wearables for Metabolic Health Pilot Study

by Jasmine Pennic 01/18/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Fitbit, the leader in wearable technology, and Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced the launch of the Wearables for Metabolic Health (WEAR-ME) pilot study.

– This pilot study will explore the potential of wearable devices to revolutionize how we assess and manage metabolic health, a key factor in preventing chronic diseases like diabetes and heart disease.

Beyond Steps: Wearables for Deeper Insights

While wearables have become our ubiquitous companions, tracking steps and sleep, their true potential lies in their ability to shed light on our internal health. WEAR-ME aims to bridge the gap between activity data and actionable health insights. By pairing Fitbit’s rich collection of biometric data with the clinical precision of Quest Diagnostics’ laboratory tests, the study will explore how these combined forces can inform a more holistic picture of metabolic health.

Data-Driven Prevention

Metabolic health, encompassing factors like blood sugar, cholesterol, and triglycerides, plays a crucial role in disease risk. Poor metabolic health paves the way for conditions like diabetes and heart disease, affecting millions worldwide. WEAR-ME seeks to break this cycle by studying the impact of wearables on user behavior, as assessed through objective lab results. Can wearables motivate us to make healthier choices that positively impact our metabolic markers? This study will delve into this critical question.

“This collaboration aligns perfectly with our mission to empower individuals to take control of their health,” says Richard Adams, Vice President and General Manager of Consumer-Initiated Testing at Quest. “By combining Fitbit’s user-friendly technology with Quest’s diagnostic expertise, we can provide people with accessible tools to understand and improve their metabolic health.”

Joining the WEAR-ME Journey

The study invites 1,500 existing Fitbit users to participate, offering them a unique opportunity to gain deeper insights into their health. Participants will share three months of Fitbit data and receive at-no-cost blood tests to assess their metabolic health profile. Armed with this personalized data, they can embark on a journey towards positive lifestyle changes, guided by the combined expertise of Fitbit and Quest.

The WEAR-ME pilot study is expected to be completed in 2024, with the findings paving the way for future research and the development of innovative strategies for managing metabolic health and preventing chronic diseases. This collaboration between Fitbit and Quest Diagnostics holds immense promise for transforming the future of healthcare, putting the power of personalized data and insights in the hands of individuals and their healthcare providers.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Fitbit, Quest Diagnostics

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |